AAAAAA

   
Results: 1-15 |
Results: 15
Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids
Authors: Grill, J Van Beusechem, VW Van de Valk, P Dirven, CMF Leonhart, A Pherai, DS Haisma, HJ Pinedo, HM Curiel, DT Gerritsen, WR
Citation: J. Grill et al., Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids, CLIN CANC R, 7(3), 2001, pp. 641-650
Selective gene delivery toward gastric and esophageal adenocarcinoma cellsvia EpCAM-targeted adenoviral vectors
Authors: Heideman, DAM Snijders, PJF Craanen, ME Bloemena, E Meijer, CJLM Meuwissen, SGM van Beusechem, VW Pinedo, HM Curiel, DT Haisma, HJ Gerritsen, WR
Citation: Dam. Heideman et al., Selective gene delivery toward gastric and esophageal adenocarcinoma cellsvia EpCAM-targeted adenoviral vectors, CANC GENE T, 8(5), 2001, pp. 342-351
Cloning and characterization of human liver cytosolic beta-glycosidase
Authors: De Graaf, M Van Veen, IC Van Der Meulen-Muileman, IH Gerritsen, WR Pinedo, HM Haisma, HJ
Citation: M. De Graaf et al., Cloning and characterization of human liver cytosolic beta-glycosidase, BIOCHEM J, 356, 2001, pp. 907-910
Pronounced antitumor efficacy of doxorubicin when given as the prodrug DOX-GA3 in combination with a monoclonal antibody beta-glucuronidase conjugate
Authors: Houba, PHJ Boven, E van der Meulen-Muileman, IH Leenders, RGG Scheeren, JW Pinedo, HM Haisma, HJ
Citation: Phj. Houba et al., Pronounced antitumor efficacy of doxorubicin when given as the prodrug DOX-GA3 in combination with a monoclonal antibody beta-glucuronidase conjugate, INT J CANC, 91(4), 2001, pp. 550-554
A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer
Authors: Houba, PHJ Boven, E van der Meulen-Muileman, IH Leenders, RGG Scheeren, JW Pinedo, HM Haisma, HJ
Citation: Phj. Houba et al., A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer, BR J CANC, 84(4), 2001, pp. 550-557
Recombinant adenovirus vectors with knobless fibers for targeted gene transfer
Authors: van Beusechem, VW van Rijswijk, ALCT van Es, HHG Haisma, HJ Pinedo, HM Gerritsen, WR
Citation: Vw. Van Beusechem et al., Recombinant adenovirus vectors with knobless fibers for targeted gene transfer, GENE THER, 7(22), 2000, pp. 1940-1946
Targeting of adenoviral vectors through a bispecific single-chain antibody
Authors: Haisma, HJ Grill, J Curiel, DT Hoogeland, S van Beusechem, VW Pinedo, HM Gerritsen, WR
Citation: Hj. Haisma et al., Targeting of adenoviral vectors through a bispecific single-chain antibody, CANC GENE T, 7(6), 2000, pp. 901-904
A rapid and versatile method for harnessing scFv antibody fragments with various biological effector functions
Authors: Helfrich, W Haisma, HJ Magdolen, V Luther, T Bom, VJJ Westra, J van der Hoeven, R Kroesen, BJ Molema, G de Leij, L
Citation: W. Helfrich et al., A rapid and versatile method for harnessing scFv antibody fragments with various biological effector functions, J IMMUNOL M, 237(1-2), 2000, pp. 131-145
Transductional targeting of adenoviral vectors to prostate cancer in vitro
Authors: Bangma, CH Kraaij, R van Rijswijk, A Haisma, HJ van Beusechem, V Gerritsen, W
Citation: Ch. Bangma et al., Transductional targeting of adenoviral vectors to prostate cancer in vitro, PROSTATE C, 2, 1999, pp. S5-S5
Cationic polymeric gene delivery of beta-glucuronidase for doxorubicin prodrug therapy
Authors: Fonseca, MJ Storm, G Hennink, WE Gerritsen, WR Haisma, HJ
Citation: Mj. Fonseca et al., Cationic polymeric gene delivery of beta-glucuronidase for doxorubicin prodrug therapy, J GENE MED, 1(6), 1999, pp. 407-414
Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM
Authors: Haisma, HJ Pinedo, HM van Rijswijk, A van der Muelen-Muileman, I Sosnowski, BA Ying, W van Beusechem, VW Tillman, BW Gerritsen, WR Curiel, DT
Citation: Hj. Haisma et al., Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM, GENE THER, 6(8), 1999, pp. 1469-1474
Novel anthracycline-spacer-beta-glucuronide, -beta-glucoside, and -beta-galactoside prodrugs for application in selective chemotherapy
Authors: Leenders, RGG Damen, EWP Bijsterveld, EJA Scheeren, HW Houba, PHJ van der Meulen-Muileman, IH Boven, E Haisma, HJ
Citation: Rgg. Leenders et al., Novel anthracycline-spacer-beta-glucuronide, -beta-glucoside, and -beta-galactoside prodrugs for application in selective chemotherapy, BIO MED CH, 7(8), 1999, pp. 1597-1610
Distribution and pharmacokinetics of the prodrug daunorubicin-GA3 in nude mice bearing human ovarian cancer xenografts
Authors: Houba, PHJ Boven, E van der Meulen-Muileman, IH Leenders, RGG Scheeren, JW Pinedo, HM Haisma, HJ
Citation: Phj. Houba et al., Distribution and pharmacokinetics of the prodrug daunorubicin-GA3 in nude mice bearing human ovarian cancer xenografts, BIOCH PHARM, 57(6), 1999, pp. 673-680
Design of immuno-enzymosomes with maximum enzyme targeting capability: effect of the enzyme density on the enzyme targeting capability and cell binding properties
Authors: Fonseca, MJ Haisma, HJ Klaasen, S Vingerhoeds, MH Storm, G
Citation: Mj. Fonseca et al., Design of immuno-enzymosomes with maximum enzyme targeting capability: effect of the enzyme density on the enzyme targeting capability and cell binding properties, BBA-BIOMEMB, 1419(2), 1999, pp. 272-282
The efficacy of the anthracycline prodrug daunorubicin-GA3 in human ovarian cancer xenografts
Authors: Houba, PHJ Boven, E Erkelens, CAM Leenders, RGG Scheeren, JW Pinedo, HM Haisma, HJ
Citation: Phj. Houba et al., The efficacy of the anthracycline prodrug daunorubicin-GA3 in human ovarian cancer xenografts, BR J CANC, 78(12), 1998, pp. 1600-1606
Risultati: 1-15 |